论文部分内容阅读
目的:探讨新斯的明联合开塞露治疗产后尿潴留的临床疗效。方法:本研究于2012年8月~2013年8月将收治的产后尿潴留产妇按照随机数字表法分为研究组和对照组,其中对照组采用常规诱导排尿的方法,研究组给予新斯的明联合开塞露治疗,比较两组产妇的治疗效果及不良反应发生率。结果:研究组患者中显效28例,有效4例,总有效率达100.00%;对照组患者中显效12例,有效10例,总有效率为68.75%;经统计分析发现研究组的总有效率明显高于对照组,且差异具有统计学意义(χ2=11.85,P<0.05)。研究组患者在治疗期间有2例产妇出现腹部疼痛,对照组出现1例出现腹部疼痛;产妇均能忍受,未进行处理。两组患者的不良反应发生率比较无明显差异(P>0.05)。结论:新斯的明联合开塞露治疗产后尿潴留疗效确切,不良反应低,值得推广使用。
Objective: To investigate the clinical efficacy of neostigmine combined with Kaixailu in the treatment of postpartum urinary retention. Methods: The study was divided into study group and control group according to the random number table from August 2012 to August 2013. The control group was given conventional urination method. The study group was given Neosi Ming combined with Kai Leli treatment, comparison of the two groups of maternal treatment and adverse reactions. Results: In the study group, 28 cases were markedly effective and 4 cases were effective. The total effective rate was 100.00%. In the control group, 12 cases were markedly effective and 10 cases were effective. The total effective rate was 68.75%. The statistical analysis showed that the total effective rate Which was significantly higher than that of the control group (χ2 = 11.85, P <0.05). In the study group, 2 maternal abdominal pain occurred in the treatment group and 1 case showed abdominal pain in the control group. All the maternal women could tolerate without treatment. There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion: Neostigmine combined with Kaisailu treatment of postpartum urinary retention exact effect, low adverse reactions, it is worth promoting the use of.